newsfilter
← Latest News
GlobeNewswire·

PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Stock

SPARTA, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and...